MDR-RT50

MTB/MDR Detection Kit

Quantity: 50 Tests

£450.00

The geneMAP™ MTB/MDR Detection Kit is engineered for the rapid and accurate detection of drug-resistant tuberculosis (TB) using multiplex real-time PCR technology. This research-use-only (RUO) kit is compatible with FAM, VIC/HEX, ROX, and CY5 four-color real-time PCR instruments, providing superior analytical sensitivity and specificity. It represents a significant advancement in TB diagnostics, offering a faster, more accessible alternative to culture-based drug susceptibility tests, which are essential for combating the global health challenge of drug-resistant TB.

The geneMAP™ MTB/MDR Detection Kit is engineered for the rapid and accurate detection of drug-resistant tuberculosis (TB) using multiplex real-time PCR technology. This research-use-only (RUO) kit is compatible with FAM, VIC/HEX, ROX, and CY5 four-color real-time PCR instruments, providing superior analytical sensitivity and specificity. It represents a significant advancement in TB diagnostics, offering a faster, more accessible alternative to culture-based drug susceptibility tests, which are essential for combating the global health challenge of drug-resistant TB.

  • Superior Analytical Sensitivity and Specificity: Ensures reliable detection of drug-resistant TB strains.
  • Multiplex Real-Time PCR Technology: Enables the simultaneous detection of multiple drug resistance markers, speeding up the diagnostic process.
  • Four-Color Compatibility: Optimized for use with real-time PCR instruments that support FAM, VIC/HEX, ROX, and CY5, allowing for comprehensive analysis.
  • RUO Designation: Intended for research purposes, aiding in the study and management of drug-resistant TB.
  • Rapid Detection of Drug-Resistant TB: Offers a quick and efficient alternative to traditional culture-based methods, facilitating early diagnosis and treatment.
  • Enhances TB Control Efforts: By enabling the timely identification of drug-resistant cases, it helps prevent the spread of TB and the development of further drug resistance.
  • Accessible Testing: Simplifies the testing process, making advanced diagnostics more accessible, especially in low- and middle-income countries where TB is most prevalent.
  • Drug-Resistance Screening: Essential for identifying drug-resistant TB strains in clinical research settings, supporting targeted treatment strategies.
  • Epidemiological Studies: Useful for monitoring and understanding the spread of drug-resistant TB, informing public health strategies and research.
  • Technology: Utilizes multiplex real-time PCR for the detection of drug resistance markers in TB.
  • Compatibility: Suitable for real-time PCR instruments supporting FAM, VIC/HEX, ROX, and CY5 detection channels.
  • Usage: Designed for research use only, not approved for diagnostic or therapeutic applications.

Product Downloads

Download essential technical information for this product.

Why Choose Clent

We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.

Fast Delivery
Dedicated Support
Satisfaction Guarantee